Phenformin enhances the therapeutic benefit of BRAFV600E inhibition in melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phenformin enhances the therapeutic benefit of BRAFV600E inhibition in melanoma

Published:2013-10-21 Issue:45 Volume:110 Page:18226-18231
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Yuan P.,Ito K.,Perez-Lorenzo R.,Del Guzzo C.,Lee J. H.,Shen C.-H.,Bosenberg M. W.,McMahon M.,Cantley L. C.,Zheng B.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference30 articles.

1. Melanoma: from mutations to medicine

2. Raf kinases in cancer–roles and therapeutic opportunities

3. From genes to drugs: targeted strategies for melanoma

4. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

5. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of mitochondria and potential of mitochondria-targeted therapy in BRAF mutant cancer: A review;Critical Reviews in Oncology/Hematology;2024-11

2. Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma;Cancer Treatment Reviews;2024-09

3. Evaluation of suppressor behavior of guanidine‐derived metformin and galegine as novel potential drugs for cancer treatment: an in silico study;Biotechnology and Applied Biochemistry;2024-07-16

4. Mitochondrial dysfunction and immune suppression in BRAF V600E‐mutated metastatic melanoma;Clinical and Translational Medicine;2024-07

5. Chemical imaging unveils mitochondria as the major site of medicinal biguanide accumulation within cells;Heliyon;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3